TAk-935
Showing 326 - 338 of 338
Hypertension Trial in Worldwide (Azilsartan Medoxomil, Valsartan)
Prostate Cancer, Prostatic Tumors Trial in Lyon (Leuprorelin, TAK-448)
Terminated
- Prostate Cancer
- Prostatic Neoplasms
-
Lyon, FranceHôpital Edouard Herriot, 5, Place d'Arsonval, Pavillon V - Urolo
Jan 26, 2012
Advanced Solid Tumors Trial in Atlanta, Philadelphia, Nashville (TAK-701)
Completed
- Advanced Solid Tumors
- TAK-701
-
Atlanta, Georgia
- +2 more
Dec 1, 2011
Cancer Trial in Indianapolis, Baltimore, Detroit (TAK-285 Dose Escalation Cohorts, TAK-285 Recommended Phase 2 Dosing Cohort)
Completed
- Cancer
- TAK-285 Dose Escalation Cohorts
- TAK-285 Recommended Phase 2 Dosing Cohort
-
Indianapolis, Indiana
- +2 more
Dec 7, 2011
Sleep Disorders, Circadian Rhythm Trial in United States (Ramelteon, Placebo)
Completed
- Sleep Disorders, Circadian Rhythm
- Ramelteon
- Placebo
-
Birmingham, Alabama
- +41 more
Feb 27, 2012
Hypertension Trial in Worldwide (Azilsartan medoxomil, Valsartan, Olmesartan)
Completed
- Hypertension
- Azilsartan medoxomil
- +3 more
-
Alabaster, Alabama
- +130 more
Mar 24, 2011
Insomnia Trial in Tucson (Placebo, Rozerem 8mg, Rozerem 8mg in combination with Multi Component Behavior Therapy)
Unknown status
- Insomnia
- Placebo
- +2 more
-
Tucson, ArizonaUniversity of Arizona Sleep Research Laboratory
Aug 11, 2010
Arthritis, Rheumatoid Trial in Worldwide (TAK-783 and methotrexate, Methotrexate)
Completed
- Arthritis, Rheumatoid
- TAK-783 and methotrexate
- Methotrexate
-
Brno-Bohunice, Czech Republic
- +24 more
Jun 9, 2010
Arthritis, Rheumatoid Trial (TAK-715 and methotrexate, Methotrexate)
Completed
- Arthritis, Rheumatoid
- TAK-715 and methotrexate
- Methotrexate
- (no location specified)
Jun 9, 2010